Does Crizotinib Interact with Calcium Channel Blockers?
CDI records a major classification for Crizotinib and Calcium Channel Blockers. The stored summary is: Non-dihydropyridine calcium channel blockers cause bradycardia and should be avoided with crizotinib, which can also cause bradycardia. The mechanism involves additive bradycardic effects. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Crizotinib Class
- Kinase Inhibitor
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Additive bradycardic effects
What To Tell Your Doctor or Pharmacist
If you are taking Crizotinib and your doctor is considering prescribing Calcium Channel Blockers (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider